Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management

Lancet. 2024 Jun 1;403(10442):2353-2355. doi: 10.1016/S0140-6736(24)00802-X. Epub 2024 May 16.

Authors

Alan Pollack¹, Alan Dal Pra²

Affiliations

¹ Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA. Electronic address: apollack@med.miami.edu.
² Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.

PMID: 38763152
DOI: 10.1016/S0140-6736(24)00802-X

No abstract available

Publication types

Comment

MeSH terms

Androgen Antagonists* / therapeutic use
Combined Modality Therapy
Humans
Male
Prostatectomy
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms* / surgery
Radiotherapy, Adjuvant
Randomized Controlled Trials as Topic

Substances

Androgen Antagonists